Table 1.
Iron parameters and reference values.
Fig 1.
Flowchart of the selection of participants with chronic paracoccidioidomycosis (PCM) from 2013 to 2021.
HIV, human immunodeficiency virus.
Table 2.
Baseline demographic, clinical, and lifestyle data of 39 patients with chronic paracoccidioidomycosis.
Fig 2.
Comparison of median serum ferritin values before treatment (BT) and at the time of clinical cure (CC) of patients with chronic paracoccidioidomycosis.
Q1, first quartile; Q3, third quartile. Wilcoxon signed rank test.
Table 3.
Comparison of the transport iron parameters before treatment and at the time of clinical cure of 30 patients with chronic paracoccidioidomycosis.
Table 4.
Comparison of functional iron parameter values before treatment and at the time of clinical cure of patients with chronic paracoccidioidomycosis.
Fig 3.
Boxplot of the inflammatory process evaluation involving CRP during different stages of PCM.
Q1, first quartile; Q3, third quartile; BT, before treatment; CC, clinical cure. Wilcoxon signed rank test.
Fig 4.
Pearson’s correlations of C-reactive protein (CRP) with variables used to evaluate the iron forms of patients with chronic paracoccidioidomycosis before treatment (n = 36 patients).
(a) Correlation of CRP with the total iron-binding capacity (TIBC). (b) Correlation of CRP with hemoglobin (Hb). (c) Correlation of CRP with red blood cells (RBCs; total erythrocyte count). (d) Correlation of CRP with hematocrit (HCT).
Table 5.
Analysis of iron parameters and CRP levels according to disease severity of patients with chronic paracoccidioidomycosis before treatment.